Description
3-Tert-butyl-5-methoxy-catechol exhibits anticancer activity, inhibiting proliferation of leukemia cells. This compound may also induce cellular differentiation in vitro.
| Product Unit Size | Cost | Quantity | Stock |
|---|
3-Tert-butyl-5-methoxy-catechol exhibits anticancer activity, inhibiting proliferation of leukemia cells. This compound may also induce cellular differentiation in vitro.
| Cas No. | 80284-15-7 |
|---|---|
| Purity | ≥95% |
| Formula | C11H16O3 |
| Formula Wt. | 196.25 |
| Chemical Name | 3-tert-butyl-5-methoxybenzene-1,2-diol |
| IUPAC Name | 3-tert-butyl-5-methoxybenzene-1,2-diol |
| Synonym | 3-(1,1-Dimethylethyl)-5-methoxy-1,2-benzenediol, 3-tert-Butyl-4,5-dihydroxyanisole |
| Melting Point | 95-96°C |
| Solubility | Partly soluble in water. |
| Appearance | White/Off-white Crystalline Solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Tsuchiya T, Ishida A, Miyata N, et al. Effects of 3-tert-Butyl-4-hydroxyanisole and its hydroquinone and quinone metabolites on rat and human embryonic cells in culture. Toxicol In Vitro. 1988;2(4):291-6. PMID: 20837439.
Lam LK, Garg PK, Swanson SM, et al. Evaluation of the cytotoxic potential of catechols and quinones structurally related to butylated hydroxyanisole. J Pharm Sci. 1988 May;77(5):393-5. PMID: 3411459.
Endogenous bombesin-related peptide, involved i...
Alkaloid found in Catharanthus, precursor in sy...
Nucleoside (cytidine) analog; DNMT inhibitor, p...
Immunodominant peptide epitope occurring in mul...
BTK and IL-2-inducible kinase inhibitor.
LBQ657 prodrug; neprilysin inhibitor.
CRTH2 inhibitor, TxA2 antagonist.
Endogenous neuropeptide, involved in opioid sig...
beta-catenin inhibitor
pan-PI3K inhibitor.
Labdane diterpene found in Andrographolis; cNOS...
Anthracycline, DNA intercalator; topoisomerase ...
BTK inhibitor.
Acyclic nucleotide (adenosine) analog, adefovir...
Alters membrane permeability, prevents transpor...
Inhibitor of EGFR.
Non-steroidal MRA
Coumarin, more potent isomer; VKORC1 inhibitor....
β1/2-adrenergic antagonist.
Synthetic ITC.